P. Zou, “Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics”, J Pharm Pharm Sci, vol. 15, no. 2, pp. 265–280, Apr. 2012.